- Home
- SWZ vs GNTA Comparison
SWZ vs GNTA Comparison
Compare SWZ & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWZ
- GNTA
- Stock Information
- Founded
- SWZ 1986
- GNTA 2014
- Country
- SWZ United States
- GNTA Italy
- Employees
- SWZ N/A
- GNTA N/A
- Industry
- SWZ Finance Companies
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SWZ Finance
- GNTA Health Care
- Exchange
- SWZ Nasdaq
- GNTA Nasdaq
- Market Cap
- SWZ 103.5M
- GNTA 96.0M
- IPO Year
- SWZ N/A
- GNTA 2021
- Fundamental
- Price
- SWZ $7.54
- GNTA $5.01
- Analyst Decision
- SWZ
- GNTA Strong Buy
- Analyst Count
- SWZ 0
- GNTA 1
- Target Price
- SWZ N/A
- GNTA $25.00
- AVG Volume (30 Days)
- SWZ 14.2K
- GNTA 5.8K
- Earning Date
- SWZ 01-01-0001
- GNTA 01-01-0001
- Dividend Yield
- SWZ 6.59%
- GNTA N/A
- EPS Growth
- SWZ N/A
- GNTA N/A
- EPS
- SWZ N/A
- GNTA N/A
- Revenue
- SWZ N/A
- GNTA N/A
- Revenue This Year
- SWZ N/A
- GNTA N/A
- Revenue Next Year
- SWZ N/A
- GNTA N/A
- P/E Ratio
- SWZ N/A
- GNTA N/A
- Revenue Growth
- SWZ N/A
- GNTA N/A
- 52 Week Low
- SWZ $7.12
- GNTA $2.20
- 52 Week High
- SWZ $8.57
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- SWZ 28.40
- GNTA 47.05
- Support Level
- SWZ $7.86
- GNTA $4.95
- Resistance Level
- SWZ $7.68
- GNTA $5.50
- Average True Range (ATR)
- SWZ 0.07
- GNTA 0.27
- MACD
- SWZ -0.02
- GNTA -0.01
- Stochastic Oscillator
- SWZ 10.02
- GNTA 45.56
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, and retail.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.